Firefly Neuroscience (AIFF) Current Deferred Revenue (2010 - 2026)

Firefly Neuroscience has reported Current Deferred Revenue for 16 years, with the latest figure at $222000.0 in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 31.9% year-over-year to $222000.0 in Q2 2026; TTM through Jun 2026 was $222000.0, a 31.9% decrease from a year earlier, with the FY2025 full-year figure at $249000.0, up 1815.38% from the prior year.
• Current Deferred Revenue was $222000.0 for Q2 2026 at Firefly Neuroscience, up from $208000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $326000.0 in Q2 2025, with the low at $2491.0 in Q3 2022.
• Average Current Deferred Revenue over 5 years is $126819.6, with a median of $87612.0 recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue plunged 96.87% in 2022, then jumped 1815.38% in 2025.
• Over 5 years, Current Deferred Revenue stood at $182756.0 in 2022, then plunged by 85.76% to $26026.0 in 2023, then sank by 50.05% to $13000.0 in 2024, then surged by 1815.38% to $249000.0 in 2025, then decreased by 10.84% to $222000.0 in 2026.
• The last three Current Deferred Revenue figures came in at $222000.0 (Q2 2026), $208000.0 (Q1 2026), and $249000.0 (Q4 2025), per Business Quant data.